Potent small molecule mouse CD22-inhibitors: exploring the interaction of the residue at C-2 of sialic acid scaffold

Bioorg Med Chem Lett. 2009 Oct 1;19(19):5573-5. doi: 10.1016/j.bmcl.2009.08.044. Epub 2009 Aug 15.

Abstract

Our previous study revealed that compound 1 (9-(4'-hydroxy-4-biphenyl)acetamido-9-deoxy-Neu5Gcalpha2-6GalOMP) has the most promising affinity for mCD22. Replacing the subterminal galactose residue of 1 with benzyl or biphenylmethyl as aglycone led to 38- and 20-fold higher potency, respectively. This discovery represents a new direction in inhibitor design suitable for pharmaceutical development.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biphenyl Compounds / chemical synthesis
  • Biphenyl Compounds / chemistry*
  • Biphenyl Compounds / pharmacology
  • Disaccharides / chemical synthesis
  • Disaccharides / chemistry*
  • Disaccharides / pharmacology
  • Mice
  • N-Acetylneuraminic Acid / chemistry*
  • Sialic Acid Binding Ig-like Lectin 2 / chemistry*
  • Sialic Acid Binding Ig-like Lectin 2 / metabolism

Substances

  • Biphenyl Compounds
  • Disaccharides
  • Sialic Acid Binding Ig-like Lectin 2
  • N-Acetylneuraminic Acid